Hokko Chemical Industry (4992) Q1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2024 earnings summary
14 Oct, 2026Executive summary
Q1 FY2024 revenue rose 1.5% YoY to ¥14,409 million, while operating, ordinary and net income declined as lower fine-chemical sales weighed on earnings.
Pesticide growth, including stronger domestic sales and exports, offset declines in fine chemicals and textile materials.
Financial highlights
Revenue was ¥14,409 million, up ¥212 million (1.5%) YoY; cost of sales rose 6.3% to ¥10,854 million.
Gross profit fell ¥430 million to ¥3,555 million; gross margin declined to 24.7% from 28.1% YoY.
Operating income fell 22.6% to ¥1,801 million; ordinary income fell 16.8% to ¥2,008 million.
Net income attributable to owners of the parent decreased 22.1% to ¥1,318 million.
Outlook and guidance
FY2024 forecasts: revenue ¥46,000 million, operating income ¥4,120 million, ordinary income ¥5,100 million and net income attributable to owners of the parent ¥3,450 million.
Q1 progress toward FY forecasts was 31.3% for revenue, 43.7% for operating income, 39.4% for ordinary income and 38.2% for net income.
Latest events from Hokko Chemical Industry
- H1 revenue and net income rose, while operating income fell amid cost pressure.4992
Q2 2024 - Revenue rose, operating profit fell on costs and competition; a share buyback was approved.4992
Q3 2024 - FY2024 earnings grew; FY2025 guidance projects higher sales and operating profit.4992
Q4 2024 - Pesticide-led growth lifted Q1 revenue; Fine Chemicals profit fell, and 5% of shares were canceled.4992
Q1 2025 - Pesticide-led growth lifted profit; earnings guidance held as the dividend forecast rose.4992
Q3 2025 - Agrochemical-led Q1 growth accompanied higher FY2029 targets.4992
Q1 2026 - Pesticide-led growth lifted H1 results as fine chemicals weakened; a buyback was approved.4992
Q2 2025 - Record ordinary profit and strong agrochemical sales; FY2026 dividend projected higher.4992
Q4 2025 - Agriculture-led H1 growth; guidance maintained and a ¥2bn share buyback approved.4992
Q2 2026